Tajuana Bradley1, Beth Sandy2

  • 1From Georgia Cancer Specialists, affiliated with Northside Hospital Cancer Institute, Lawrenceville, Georgia.

概括

生物标志物测试和最近的FDA批准正在改变转移性非小细胞肺癌的治疗方法. 讨论了针对性和组合疗法的不良事件管理的最佳实践.